Lifshitz & Miller LLP Announces Investigation of Neon Therapeutics, Inc., Stein Mart, Inc., and Taubman Centers, Inc.

Author's Avatar
Marketwired
Mar 11, 2020
Article's Main Image

NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) --

Neon Therapeutics, Inc. (

NTGN, Financial)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of NTGN to BioNTech SE.

If you are a NTGN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Stein Mart, Inc. (

SMRT, Financial)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of SMRT to Kingswood Capital Management, L.P. for $0.90 per share.

If you are a SMRT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Taubman Centers, Inc. (:TCO)

Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the sale of Taubman to Simon Property Group, Inc. for $52.50 per share.

If you are a Taubman investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. 2020 Lifshitz & Miller LLP. The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone: 516-493-9780

Facsimile: 516-280-7376
Email: [email protected]


ti?nf=Nzg2ODI0MiMzMzk0Mzc2IzIxODI0NTM=
Rating:
0 / 5 (0 votes)

Please Login to leave a comment

Please Login to leave a comment